Hemp Health Spolka Akcyjna Logo

Hemp Health Spolka Akcyjna

Manages a supply chain for medical marijuana, from cultivation to distribution.

HMP | WAR

Overview

Corporate Details

ISIN(s):
PLEBCSL00011 (+4 more)
LEI:
259400HT196UIMTSG008
Country:
Poland
Address:
WARSZAWA JANA STYKI 23, 03-928 WARSZAWA

Description

Hemp Health Spolka Akcyjna operates at the intersection of the hemp and health sectors. The company's strategy focuses on creating and managing a complete supply chain for medical marijuana, encompassing its own cultivation, importation, processing, and distribution. Its business activities also include the distribution of CBD and THC products, research and development, and offering white-label services. The company aims to become a leader in the cultivation of medical-grade cannabis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-31 12:34
zal03_HHSA-formularz-pelnomocnictwa.pdf
Polish 286.0 KB
2025-12-31 12:34
zal01_HHSA-projekty-uchwal.pdf
Polish 232.5 KB
2025-12-31 12:34
zal02_HHSA-ogloszenie.pdf
Polish 241.6 KB
2025-12-31 12:34
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 28 stycznia 2026 roku - C…
Polish 707 bytes
2025-12-31 12:02
Odwołanie Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
Polish 544 bytes
2025-12-29 18:00
Zbycie udziałów Certis Pharma sp. z o.o. - Content (PL)
Polish 716 bytes
2025-12-29 17:59
Zbycie akcji THC Pharma S.A. - Content (PL)
Polish 689 bytes
2025-12-19 12:03
zal02_HHSA-formularz-pelnomocnictwa-uzupelnione.pdf
Polish 285.9 KB
2025-12-19 12:03
zal01_HHSA-projekty-uchwal-uzupelnione.pdf
Polish 232.1 KB
2025-12-19 12:03
zal03_HHSA-ogloszenie-uzupelnione.pdf
Polish 241.2 KB
2025-12-19 12:03
Wprowadzenie, na żądanie akcjonariuszy, zmian do porządku obrad Nadzwyczajnego …
Polish 1.5 KB
2025-12-09 21:19
zal02_HHSA-formularz-pelnomocnictwa.pdf
Polish 249.3 KB
2025-12-09 21:19
zal03_HHSA-projekty-uchwal.pdf
Polish 217.0 KB
2025-12-09 21:19
zal01_HHSA-ogloszenie.pdf
Polish 238.5 KB
2025-12-09 21:19
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 7 stycznia 2026 roku - Co…
Polish 705 bytes

Automate Your Workflow. Get a real-time feed of all Hemp Health Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hemp Health Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hemp Health Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.